Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome

Journal of Clinical Microbiology

Volumn 39, Issue 7, 2001, Pages 2458-2462

  Wenisch, C ^a   Moore, C B ^a   Krause, R ^a   Presterl, E ^a   Pichna, P ^a   Denning, D W ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN; FLUCONAZOLE;

ADULT; AGED; ARTICLE; BLOOD CULTURE; CANDIDA; CANDIDIASIS; CLINICAL ARTICLE; DRUG SENSITIVITY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; FUNGUS; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIFUNGAL AGENTS; BLOOD; CANDIDA; CANDIDIASIS; CULTURE MEDIA; DRUG RESISTANCE, MICROBIAL; FEMALE; FLOW CYTOMETRY; FLUCONAZOLE; FUNGEMIA; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TREATMENT OUTCOME;

CANDIDA; FUNGI;

EID: 0034957804     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.7.2458-2462.2001     Document Type: Article

References (28)

1. Correlation between in vitro and in vivo activity of antifungal agents against Candida species
2. Characterization and quantitation of the pharmacodynamics of fluconazole in a neutropenic murine disseminated candidiasis infection model
3. The emergence of fungi as major hospital pathogens
4. Results of survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B
5. Comparison of relative susceptibilities of Candida species to three antifungal agents as determined by unstandardized methods
6. Susceptibility testing of fungi: Current status of correlation of in vitro data with clinical outcome
7. Treatment of Candida albicans fungaemia with fluconazole
8. Rapid determination of antifungal activity by flow cytometry
9. Rapid susceptibility testing of Candida albicans by flow cytometry
10. Clinical correlates of antifungal macrodilution susceptibility test results for non-AIDS patients with severe Candida infections treated with fluconazole
11. Pharmacodynamics of fluconazole in a murine model of systemic candidiasis
12. Pharmacokinetic studies of fluconazole in rabbits characterizing doses which achieve peak levels in serum and area under the concentration-time curve values which mimic those of high-dose fluconazole in humans
13. Candida lusitaniae: Frequency of recovery, colonization, infection, and amphotericin B resistance
14. Multicenter randomized trial of fluconazole versus amphotericin B for the treatment of candidemia in non neutropenic patients
15. Antibiotic susceptibility, testing of Candida albicans by flow cytometry
16. Amphotericin B-resistant yeast infection in severely immunocompromised patients
17. Flow cytometry antifungal susceptibility testing of pathogenic yeasts other than Candida albicans and comparison with the NCCLS broth microdilution test
18. Rapid flow cytometric susceptibility testing of Candida albicans
19. A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia
20. Detection of amphotericin B-resistant Candida isolates in a broth-based system
21. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment on nonneutropenic patients with candidemia
22. Development of interpretive breakpoints for antifungal susceptibility testing: Conceptual framework and analysis of in vitro-in vivo correlation data for fluconazole, itraconazole, and candida infections: Subcommittee on Antifungal Susceptibility Testing of the National Committee for Clinical Laboratory Standards
23. Antifungal susceptibility testing
24. Practice guidelines for the treatment of candidiasis
25. Rapid susceptibility testing of fungi by flow cytometry using vital staining
26. Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole